Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Row breaks out over WHO trial casting doubt on remdesivir as COVID-19 drug

Reuters Health - A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19.

Read the full article here

Related Content